Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Income (2023 - 2025)

Metagenomi (MGX) has disclosed Net Income for 3 consecutive years, with -$22.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 3.72% to -$22.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$87.9 million, a 12.57% decrease, with the full-year FY2025 number at -$87.9 million, down 12.57% from a year prior.
  • Net Income was -$22.5 million for Q4 2025 at Metagenomi, down from -$20.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$10.7 million in Q2 2024 to a low of -$25.1 million in Q1 2024.
  • A 3-year average of -$19.5 million and a median of -$19.9 million in 2023 define the central range for Net Income.
  • Biggest YoY gain for Net Income was 38.29% in 2024; the steepest drop was 114.23% in 2024.
  • Metagenomi's Net Income stood at -$19.3 million in 2023, then fell by 21.27% to -$23.4 million in 2024, then increased by 3.72% to -$22.5 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Net Income are -$22.5 million (Q4 2025), -$20.4 million (Q3 2025), and -$19.9 million (Q2 2025).